Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development.
adenosine
immune checkpoints
immune evasion
immunotherapy
lipid mediators
signal networks
Journal
The Biochemical journal
ISSN: 1470-8728
Titre abrégé: Biochem J
Pays: England
ID NLM: 2984726R
Informations de publication
Date de publication:
28 10 2022
28 10 2022
Historique:
received:
01
07
2022
revised:
03
10
2022
accepted:
05
10
2022
entrez:
28
10
2022
pubmed:
29
10
2022
medline:
2
11
2022
Statut:
ppublish
Résumé
Through activation of immune cells, the immune system is responsible for identifying and destroying infected or otherwise damaged cells including tumorigenic cells that can be recognized as foreign, thus maintaining homeostasis. However, tumor cells have evolved several mechanisms to avoid immune cell detection and killing, resulting in tumor growth and progression. In the tumor microenvironment, tumor infiltrating immune cells are inactivated by soluble factors or tumor promoting conditions and lose their effects on tumor cells. Analysis of signaling and crosstalk between immune cells and tumor cells have helped us to understand in more detail the mechanisms of tumor immune evasion and this forms basis for drug development strategies in the area of cancer immunotherapy. In this review, we will summarize the dominant signaling networks involved in immune escape and describe the status of development of therapeutic strategies to target tumor immune evasion mechanisms with focus on how the tumor microenvironment interacts with T cells.
Identifiants
pubmed: 36305711
pii: 232000
doi: 10.1042/BCJ20210233
doi:
Types de publication
Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2219-2260Informations de copyright
© 2022 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.